CD55 anticorps (AA 35-126)

N° du produit ABIN7148376

Détail du produit anti-CD55 anticorps

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Épitope: AA 35-126

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CD55 est non-conjugé

Application: Immunohistochemistry (IHC), Immunofluorescence (IF), ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Complement decay-accelerating factor protein (35-126AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur CD55

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Autre désignation: CD55 (CD55 Produits)

Synonymes: anticorps CR, anticorps CROM, anticorps DAF, anticorps TC, anticorps Daf, anticorps Daf-GPI, anticorps Daf1, anticorps GPI-DAF, anticorps CD55 molecule (Cromer blood group), anticorps CD55 molecule, decay accelerating factor for complement, anticorps CD55, anticorps Cd55

Sujet:

Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.

Aliases: CD 55 antibody, CD55 antibody, CD55 antigen antibody, CD55 Cromer blood group system antibody, CD55 Molecule (Cromer blood group) antibody, CD55 Molecule antibody, CD55 Molecule, decay accelerating factor for complement (Cromer blood group) antibody, Cd55a antibody, Complement decay accelerating factor antibody, Complement decay-accelerating factor antibody, Complement decay-accelerating factor, GPI-anchored antibody, CR antibody, CROM antibody, Cromer Blood Group antigen antibody, Cromer blood group system antibody, DAF antibody, Daf-GPI antibody, DAF_HUMAN antibody, Daf1 antibody, Dcay accelerating factor for complement (CD55, Cromer blood group system) antibody, Decay accelarating factor 1, isoform CRA_a antibody, Decay accelerating factor (GPI-form) antibody, Decay Accelerating Factor for Complement antibody, Decay accelerating factor GPI-form antibody, Decay accelerating factor soluble-form antibody, GPI-DAF antibody, TC antibody

UniProt: P08174

Pathways: Système du Complément, Regulation of Leukocyte Mediated Immunity